AOD 9604 clinical trials show only modest weight loss in humans, and the peptide is not FDA-approved. Here's what the studies found and what it means.
AOD-9604 clinical trials have not shown a reliable or clinically meaningful weight-loss effect in humans. In the largest human studies, the peptide produced only about 1 to 2 kg (2 to 4 lb) more weight loss than placebo over roughly 12 weeks, and development as an obesity drug was discontinued. AOD-9604 is not FDA-approved for any human use in the United States.
What Is AOD-9604?
AOD-9604 is a synthetic fragment of human growth hormone, built from the final 16 amino acids of the HGH molecule (residues 176–191). It also goes by names like lipotropin and HGH 176-191. Scientists designed it to isolate growth hormone's fat-metabolizing effects while removing the parts tied to blood sugar swings and tissue growth.
In cell and animal research, AOD-9604 triggers lipolysis (fat breakdown) and blocks new fat storage. That mechanism is why it is marketed as a fat burning peptide, even though human outcomes have been far more modest than the marketing suggests.
What the Clinical Trials Actually Show
The key human studies of AOD-9604 were run in the early 2000s by an Australian biotech company. Participants were obese adults who received daily subcutaneous injections for 8 to 12 weeks while researchers tracked body weight, fat mass, and waist circumference.
Three findings stand out:
- Average weight loss was small — roughly 1 to 2 kg more than placebo in most published summaries.
- Changes in fat mass and waist circumference were similarly modest.
- Larger, later-stage trials did not confirm a strong enough benefit, and the obesity program was discontinued.
Human studies of AOD-9604 were also short. No trial followed participants for years, so there is no long-term safety or durability data for healthy adults using it for cosmetic fat loss.
| Trial stage | Participants | Typical dose and duration | Reported result |
|---|---|---|---|
| Early Phase II | Obese adults | About 1 mg/day injected, 12 weeks | Statistically detectable but small weight loss |
| Larger Phase II | Several hundred obese adults | 1–3 mg/day injected, 8–12 weeks | Weight loss not clinically meaningful versus placebo |
| Later development | Obesity indication | Various | Program discontinued; no approval pursued |
Public summaries of these trials vary in detail, so treat specific numbers as approximate rather than precise.
Does AOD-9604 Work for Weight Loss?
If you are asking yourself "aod 9604 does it work," the published answer is: not well enough to serve as a weight-loss treatment on its own. The peptide does appear to do something in humans, but the effect is small compared with diet, exercise, or approved obesity medications.
People also search for how fast AOD 9604 works and how long results take. In the trials, changes were measured over 8 to 12 weeks, not days. Users who report "aod 9604 not working" are often describing the same pattern seen in the research: subtle or undetectable changes over a short course.
Placebo effects matter here too. In weight-loss trials, placebo groups frequently lose several pounds from behavior changes alone, which can make a small drug effect hard to feel.
Is AOD-9604 FDA-Approved? Safety and Legal Status
AOD-9604 is not approved by the FDA for any human use, and it has not been approved as a prescription drug in other countries either. In the US it is legally sold only as a research chemical for laboratory study, not for human consumption.
Reported side effects in trials were generally mild — injection-site irritation, headache, and nausea — but the safety database is small. Because research-chemical vials are not held to pharmaceutical manufacturing standards, purity and actual dose can differ from the label.
Before considering any peptide, review aod 9604 benefits and side effects with a clinician who knows your health history. AOD-9604 is not a substitute for medical care, and it should not be used during pregnancy, by people with a cancer history, or alongside other hormone therapies without medical supervision.
Other Research: Osteoarthritis, Lipotropin, and Fat Metabolism
Obesity is not the only area researchers have explored. Small, early-stage studies have tested AOD-9604 injected into the knee joint for osteoarthritis pain, and those results remain preliminary. Interest in lipotropin aod 9604 stems from its ability to act on fat cells without raising IGF-1 or blood sugar the way full growth hormone can.
Mechanistic promise is not the same as proven benefit, though. A peptide can change fat metabolism in a petri dish or a rat and still produce disappointing results in people.
Practical Questions: Forms, Dosing, and Comparisons
Some vendors sell AOD-9604 as an injectable powder, while others market sublingual troches, nasal sprays, or creams. There are no published human trials of troches, so any "aod 9604 troche before and after" photo you see online is anecdotal and cannot be verified.
Users frequently look up aod 9604 dosage, and typical internet protocols are far shorter and lower than the doses used in clinical trials. If you handle the injectable form, aod 9604 reconstitution requires mixing lyophilized powder with bacteriostatic water and calculating units carefully, since math errors are a common cause of bad reactions.
Comparison shopping is another common step. A frequent question is aod 9604 vs tesamorelin, but the two are not equivalent: tesamorelin is FDA-approved for excess abdominal fat in people with HIV, while AOD-9604 has no approval and weaker human data. Browsing aod 9604 reviews can help you spot red flags, but online reviews are unverified and are often written by sellers.
If you ultimately decide to use it, do so under medical supervision, buy only from sources that publish third-party purity testing, and stop if you notice unusual symptoms. Talk to a healthcare professional before starting any peptide, especially if you take medication for diabetes, thyroid conditions, or blood clotting.
Frequently Asked Questions
Does AOD 9604 actually work for weight loss?
In human clinical trials, AOD-9604 produced only about 1 to 2 kg (2 to 4 lb) more weight loss than placebo over 8 to 12 weeks. Larger trials did not confirm a clinically meaningful benefit, and the drug was never approved for weight loss. For practical purposes, it does not work well enough to be a standalone weight-loss treatment.
Is AOD 9604 FDA approved?
No. AOD-9604 is not FDA-approved for any human use, including weight loss, and it has not been approved as a prescription drug in other countries either. In the US it is sold only as a research chemical for laboratory use, which means it is not held to pharmaceutical quality standards.
How much weight loss does AOD 9604 cause, and how long does it take?
Trial participants lost roughly 1 to 2 kg (2 to 4 lb) more than those on placebo, with results measured over 8 to 12 weeks. Some individuals lost more and some lost nothing. There is no reliable evidence that AOD-9604 produces rapid or dramatic fat loss at any dose.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.